Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Biotech Industry – Zacks Analyst Interviews

Zacks Market Commentaries (June 1st, 2009) Writes:
OVERVIEW

The Biotech industry as a whole continues to underperform the market so far this year. As of May 26, 2009, Both the AMEX Biotech Index and the broader NASDAQ Biotech Index declined 6.8% (AMEX Biotech has 20 biotech companies while NASDAQ Biotech Index includes over 130 component companies), while the Dow Jones Biotech Index declined 3% (which includes 33 companies).

At the same time, both the NASDAQ Composite and S&P 500 have achieved positive returns. NASDAQ has made a gain of 11% as of 5/26/09 and the S&P 500 has gained 0.8%, while the Dow Jones Industrials reached a negative 3.5% return.

This constitutes a sharp contrast with last year when the Biotech industry as a whole achieved much better performance than the market. In 2008, all three biotech indices outperformed all three major market indices by a large margin. The three major indices declined as much as over 40% (34%, 41%

...
More »

Posted in Market Commentary, Stocks to Watch | No Comments »

Biotech Industry – Industry Outlook

Zacks Market Commentaries (May 29th, 2009) Writes:
OVERVIEWThe Biotech industry as a whole continues to underperform the market so far this year. As of May 26, 2009, Both the AMEX Biotech Index and the broader NASDAQ Biotech Index declined 6.8% (AMEX Biotech has 20 biotech companies while NASDAQ Biotech Index includes over 130 component companies), while the Dow Jones Biotech Index declined 3% (which includes 33 companies).At the same time, both the NASDAQ Composite and S&P 500 have achieved positive returns. NASDAQ has made a gain of 11% as of 5/26/09 and the S&P 500 has gained 0.8%, while the Dow Jones Industrials reached a negative 3.5% return.This constitutes a sharp contrast with last year when the Biotech industry as a whole achieved much better performance than the market. In 2008, all three biotech indices outperformed all three major market indices by a large margin. The three major indices declined ...
More »

Posted in Market Commentary, Stocks to Watch | No Comments »

Biotech Industry – Industry Outlook

Zacks Market Commentaries (April 17th, 2009) Writes:
Last year, the Biotech industry as a whole achieved much better performance than the market. Both the NASDAQ Biotech Index and AMEX Biotech Index outperformed all three major market indices (Dow Jones Industrial Average, NASDAQ Composite and S&P 500) in a large margin. The major indices declined as much as 40%. While NASDAQ Biotech Index declined only 12.6%, and AMEX Biotech Index was down 17.7%.

However, when the recession enters into its third year, the Biotech industry is not doing better than the market, which has been evident by the indices' performances. As of April 9, 2009, AMEX Biotech Index declined 3%, and the broader NASDAQ Biotech Index was down 6.8% (AMEX Biotech has 20 biotech companies while NASDAQ Biotech Index includes over 130 component companies). Although the Dow and S&P 500 also declined a similar percentage, technology-laden NASDAQ actually has a gain of 4.8%, which is more comparable to the

...
More »
Tags for this Post:
16x;, 3sbio Inc, 4Q08;, Abbott;, AMAG Pharmaceuticals Inc.;, anemia, Bayer, Biopharmaceutical, BTG International Limited;, Byetta, cancer, Canon DC230 1MP DVD Camcorder with 35x Optical Zoom;, Celera Group;, Celgene Corp.;, Cell Therapeutics Inc., China, chronic kidney disease;, Cv Therapeutics, Dow 30, drug maker, Fda, Ferumoxytol;, Genentech, Genta Inc.;, Japan, kidney cancer, Liver Cancer, Market Commentary, Merck, molecular diagnostic and therapeutic products;, Myriad Genetics;, NASDAQ biotech, Nexavar, Novo Nordisk, oncology and cancer;, Onyx Pharmaceuticals Inc, pancreatitis, Pfizer, Pharmaceutical Products, Risperdal Consta;, Roche, SB1578;, Schering-Plough Corp., schizophrenia, Singapore, Sp 500, Stocks to Watch, superparamagnetic iron oxide nanoparticles;, SurModics Inc., therapeutics for nephrology, therapy for anemia in chronic kidney disease;, thrombocytopenia, thyroid cancer;, tumors, United States, USD, Wyeth, Yahoo, Zacks Market Commentaries

Posted in Market Commentary, Stocks to Watch | No Comments »

Biotech Industry – Zacks Analyst Interviews

Zacks Market Commentaries (April 17th, 2009) Writes:
Last year, the Biotech industry as a whole achieved much better performance than the market. Both the NASDAQ Biotech Index and AMEX Biotech Index outperformed all three major market indices (Dow Jones Industrial Average, NASDAQ Composite and S&P 500) in a large margin. The major indices declined as much as 40%. While NASDAQ Biotech Index declined only 12.6%, and AMEX Biotech Index was down 17.7%.

However, when the recession enters into its third year, the Biotech industry is not doing better than the market, which has been evident by the indices' performances. As of April 9, 2009, AMEX Biotech Index declined 3%, and the broader NASDAQ Biotech Index was down 6.8% (AMEX Biotech has 20 biotech companies while NASDAQ Biotech Index includes over 130 component companies). Although the Dow and S&P 500 also declined a similar percentage, technology-laden NASDAQ actually has a gain of 4.8%, which is more comparable to the

...
More »
Tags for this Post:
16x;, 3sbio Inc, 4Q08;, Abbott;, AMAG Pharmaceuticals Inc.;, anemia, Bayer, Biopharmaceutical, Biotech Industry - Zacks;, BTG International Limited;, Byetta, cancer, Canon DC230 1MP DVD Camcorder with 35x Optical Zoom;, Celera Group;, Celgene Corp.;, Cell Therapeutics Inc., China, chronic kidney disease;, Cv Therapeutics, Dow 30, drug maker, Fda, Ferumoxytol;, Genentech, Genta Inc.;, Interviews Last;, Japan, kidney cancer, Liver Cancer, Market Commentary, Merck, molecular diagnostic and therapeutic products;, Myriad Genetics;, NASDAQ biotech, Nexavar, Novo Nordisk, oncology and cancer;, Onyx Pharmaceuticals Inc, pancreatitis, Pfizer, Pharmaceutical Products, Risperdal Consta;, Roche, SB1578;, Schering-Plough Corp., schizophrenia, Singapore, Sp 500, Stocks to Watch, superparamagnetic iron oxide nanoparticles;, SurModics Inc., therapeutics for nephrology, therapy for anemia in chronic kidney disease;, thrombocytopenia, thyroid cancer;, tumors, United States, USD, Wyeth, Yahoo, Zacks Market Commentaries

Posted in Market Commentary, Stocks to Watch | No Comments »


Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.